These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10824925)

  • 1. KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit.
    Miettinen M; Sarlomo-Rikala M; Lasota J
    Mod Pathol; 2000 May; 13(5):536-41. PubMed ID: 10824925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.
    Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R
    J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
    Folpe AL; Veikkola T; Valtola R; Weiss SW
    Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant.
    Wardelmann E; Neidt I; Bierhoff E; Speidel N; Manegold C; Fischer HP; Pfeifer U; Pietsch T
    Mod Pathol; 2002 Feb; 15(2):125-36. PubMed ID: 11850541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.
    Do I; Araujo ES; Kalil RK; Bacchini P; Bertoni F; Unni KK; Park YK
    Pathol Res Pract; 2007; 203(3):127-34. PubMed ID: 17298867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
    Zheng S; Chen LR; Wang HJ; Chen SZ
    Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors.
    Partanen TA; Alitalo K; Miettinen M
    Cancer; 1999 Dec; 86(11):2406-12. PubMed ID: 10590384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of keratins in normal endothelial cells and a spectrum of vascular tumors: implications in tumor diagnosis.
    Miettinen M; Fetsch JF
    Hum Pathol; 2000 Sep; 31(9):1062-7. PubMed ID: 11014572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.
    Heinrich MC; Corless CL; Demetri GD; Blanke CD; von Mehren M; Joensuu H; McGreevey LS; Chen CJ; Van den Abbeele AD; Druker BJ; Kiese B; Eisenberg B; Roberts PJ; Singer S; Fletcher CD; Silberman S; Dimitrijevic S; Fletcher JA
    J Clin Oncol; 2003 Dec; 21(23):4342-9. PubMed ID: 14645423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
    Miettinen M; Wang ZF; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma.
    Holst VA; Marshall CE; Moskaluk CA; Frierson HF
    Mod Pathol; 1999 Oct; 12(10):956-60. PubMed ID: 10530560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of gene mutations in KIT-positive thymic epithelial tumors.
    Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
    Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.
    Biermann K; Göke F; Nettersheim D; Eckert D; Zhou H; Kahl P; Gashaw I; Schorle H; Büttner R
    J Pathol; 2007 Nov; 213(3):311-8. PubMed ID: 17768701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic assessment of postradiation sarcomas: KIT as a potential treatment target.
    Komdeur R; Hoekstra HJ; Molenaar WM; Van Den Berg E; Zwart N; Pras E; Plaza-Menacho I; Hofstra RM; Van Der Graaf WT
    Clin Cancer Res; 2003 Aug; 9(8):2926-32. PubMed ID: 12912938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of GIST/GIPACT tumors by inmunohistochemistry and exon 11 analysis of c-kit by PCR.
    Bernet L; Zuñiga A; Cano R
    Rev Esp Enferm Dig; 2003 Oct; 95(10):688-91, 683-7. PubMed ID: 14588063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling.
    Tarn C; Merkel E; Canutescu AA; Shen W; Skorobogatko Y; Heslin MJ; Eisenberg B; Birbe R; Patchefsky A; Dunbrack R; Arnoletti JP; von Mehren M; Godwin AK
    Clin Cancer Res; 2005 May; 11(10):3668-77. PubMed ID: 15897563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas.
    Liau JY; Tsai JH; Yang CY; Lee JC; Liang CW; Hsu HH; Jeng YM
    Hum Pathol; 2015 Sep; 46(9):1360-6. PubMed ID: 26190196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent c-Kit gene mutations not only in gastrointestinal stromal tumors but also in interstitial cells of Cajal in surrounding normal mucosa.
    Ogasawara N; Tsukamoto T; Inada K; Mizoshita T; Ban N; Yamao K; Joh T; Itoh M; Tatematsu M
    Cancer Lett; 2005 Dec; 230(2):199-210. PubMed ID: 16297706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site.
    Antonescu CR; Viale A; Sarran L; Tschernyavsky SJ; Gonen M; Segal NH; Maki RG; Socci ND; DeMatteo RP; Besmer P
    Clin Cancer Res; 2004 May; 10(10):3282-90. PubMed ID: 15161681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).
    Du CY; Shi YQ; Zhou Y; Fu H; Zhao G
    J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.